Health status of ayahuasca users

Barbosa, Paulo Cesar Ribeiro; Mizumoto, Suely; Bogenschutz, Michael P.; Strassman, Rick J.

doi:10.1002/dta.1383

Cited by 112Psychedelics and Drug StudiesAlkaloids: synthesis and pharmacologyForensic Toxicology and Drug Analysis

Health status of ayahuasca users

Barbosa, Paulo Cesar Ribeiro, Mizumoto, Suely, Bogenschutz, Michael P., Strassman, Rick J.·2012·Drug Testing and Analysis

DOI 10.1002/dta.1383

Open this paper in CoChat — free account

Abstract

Ayahuasca is a psychedelic brew originally used for magico-religious purposes by Amerindian populations of the western Amazon Basin. Throughout the last four decades, the use of ayahuasca spread towards major cities in all regions of Brazil and abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine- and harmala-alkaloid-containing tea may lead to mental and physical health problems associated typically with drug abuse. To further elucidate the mental and physical health of ayahuasca users, we conducted a literature search in the international medical PubMed database. Inclusion criteria were evaluation of any related effect of ayahuasca use that occurred after the resolution of acute effects of the brew. Fifteen publications were related to emotional, cognitive, and physical health of ayahuasca users. The accumulated data suggest that ayahuasca use is safe and may even be, under certain conditions, beneficial. However, methodological bias of the reviewed studies might have contributed to the preponderance of beneficial effects and to the few adverse effects reported. The data up to now do not appear to allow for definitive conclusions to be drawn on the effects of ayahuasca use on mental and physical health, but some studies point in the direction of beneficial effects. Additional studies are suggested to provide further clarification.

Integrity signals

Registry

Crossref · 10.1002/dta.1383

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Traditional ayahuasca is relatively safe, especially when consumed in a ritualized setting, but its effects can be unpredictable due to varying combinations and concentrations of plant-based ingredients and interindividual differences in gastrointestinal absorption.
“While traditional ayahuasca is relatively safe, especially when consumed in a ritualized setting (46), its effects can be unpredictable due to varying combinations and concentrations of plant-based ingredients and interindividual differences in gastrointestinal absorption.”
From Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects (2024) · cites this paper as [46]

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · see citing works
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203 · see citing works
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905 · see citing works
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895 · see citing works
Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · see citing works
Self-citation
Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of ayahuasca
McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398 · see citing works
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390 · see citing works
Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338 · see citing works
Self-citation
Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.03.002 · Cited by 321 · see citing works
Pharmacokinetics of Hoasca alkaloids in healthy humans
Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., Andrade, E. O., Andrade, E. O., & Mash, D. C. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00168-8 · Cited by 318 · see citing works
Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303 · see citing works
Implications of LSD and experimental mysticism
Pahnke, W. N., & Richards, W. A. (1966) · Journal of Religion and Health · doi:10.1007/bf01532646 · Cited by 254 · see citing works
Assessment of addiction severity among ritual users of ayahuasca.
Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227 · see citing works
Self-citation
The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper, K. W. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.11.001 · Cited by 212 · see citing works
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members
SANTOS, R. G. D., Landeira-Fernández, J., Strassman, R. J., Motta, V., & Cruz, A. P. D. M. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.04.012 · Cited by 205 · see citing works
Self-citation
The Shaman and the Jaguar: A Study of Narcotic Drugs Among the Indians of Colombia.
de Ríos, M. D., & Reichel-Dolmatoff, G. (1975) · Man · doi:10.2307/2800162 · Cited by 182 · see citing works
Quantitation of N,N-dimethyltryptamine and Harmala alkaloids in human plasma after Oral dosing with Ayahuasca
Callaway, J. C., Raymon, L. P., Hearn, W. L., McKenna, D. J., Grob, C. S., Brito, G. S., & Mash, D. C. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.6.492 · Cited by 160 · see citing works
Drug Tourism or Spiritual Healing? Ayahuasca Seekers in Amazonia
Winkelman, M. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399803 · Cited by 157 · see citing works
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
Fortunato, J. J., Réus, G. Z., Kirsch, T. R., Stringari, R. B., Stertz, L., Kapczinski, F., Pinto, J. P., Hallak, J. E., Zuardi, A. W., Crippa, J. A., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.021 · Cited by 150 · see citing works
Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions
Callaway, J. C., & Grob, C. S. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399712 · Cited by 137 · see citing works
Untitled work
(2008) · PubMed · Cited by 130 · see citing works
Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
Doering-Silveira, E., Grob, C. S., de Rios, M. D., Lopez, E., Alonso, L. K., Tacla, C., & Da Silveira, D. X. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399794 · Cited by 122 · see citing works
‘Altered States of Consciousness and Short-Term Psychological After-Effects Induced by the First Time Ritual Use of Ayahuasca in an Urban Context in Brazil’
Barbosa, P. C. R., Giglio, J. S., & Dalgalarrondo, P. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399801 · Cited by 120 · see citing works
Self-citation
Ayahuasca in Adolescence: A Preliminary Psychiatric Assessment
Da Silveira, D. X., Grob, C. S., de Rios, M. D., Lopez, E., Alonso, L. K., Tacla, C., & Doering-Silveira, E. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399792 · Cited by 113 · see citing works
Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice
Tupper, K. W. (2008) · Global Networks · doi:10.1111/j.1471-0374.2009.00245.x · Cited by 112 · see citing works
A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects
Barbosa, P. C. R., Cazorla, I. M., Giglio, J. S., & Strassman, R. J. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10400530 · Cited by 108 · see citing works
Self-citation
Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties
Fortunato, J. J., Réus, G. Z., Kirsch, T. R., Stringari, R. B., Fries, G. R., Kapczinski, F. P., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., & Quevedo, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.008 · Cited by 99 · see citing works
Experiences of encounters with Ayahuasca–“the vine of the soul”
Kjellgren, A., Eriksson, A., & Norlander, T. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10399767 · Cited by 97 · see citing works
Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
Strassman, R. (1995) · Journal of Nervous and Mental Disease · doi:10.1097/00005053-199503000-00002 · Cited by 96 · see citing works
Self-citation
Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca
Yritia, M., Jordi Riba, A., Ortuño, J., Ramirez, A., Castillo, A., Alfaro, Y., de la Torre, R., & Barbanoj, M. J. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00397-5 · Cited by 85 · see citing works
Platelet serotonin uptake sites increased in drinkers ofayahuasca
Callaway, J. C., Airaksinen, M. M., McKenna, D. J., Brito, G. S., & Grob, C. S. (1994) · Psychopharmacology · doi:10.1007/bf02245347 · Cited by 81 · see citing works
Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
Barbanoj, M. J., Jordi Riba, A., Clos, S., Giménez, S., Grasa, E., & Romero, S. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0963-0 · Cited by 75 · see citing works
Ayahuasca in Adolescence: A Neuropsychological Assessment
Doering-Silveira, E., López, E., Grob, C. S., de Ríos, M. D., Alonso, L. K., Tacla, C., Shirakawa, I., Bertolucci, P. H. F., & da Silveira, D. X. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399791 · Cited by 72 · see citing works
Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users
Cakic, V., Potkonyak, J., & Marshall, A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.015 · Cited by 72 · see citing works
Changes in Spirituality Among Ayahuasca Ceremony Novice Participants
Trichter, S., Klimo, J., & Krippner, S. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10399905 · Cited by 71 · see citing works
The Shaman and the Jaguar: A Study of Narcotic Drugs among the Indians of Colombia.
Vickers, W. T., & Reichel‐Dolmatoff, G. (1977) · Hispanic American Historical Review · doi:10.2307/2513818 · Cited by 71 · see citing works
Bringing Ayahuasca to the Clinical Research Laboratory
Jordi Riba, A., & Barbanoj, M. J. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399804 · Cited by 58 · see citing works
Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography–electrospray ionization-tandem mass spectrometry
McIlhenny, E. H., Pipkin, K. E., Standish, L. J., Wechkin, H. A., Strassman, R. J., & Barker, S. A. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.10.088 · Cited by 58 · see citing works
Self-citation
Perspectives and prospects
WASHBURN, S. L. (1967) · American Journal of Physical Anthropology · doi:10.1002/ajpa.1330270309 · Cited by 51 · see citing works
A Hallucinogenic Tea, Laced With Controversy. Ayahuasca in the Amazon and the United States
de Ríos, M. D., & Rumrrill, R. (2009) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2009.00325.x · Cited by 50 · see citing works
Drug Tourism in the Amazon
deRios, M. D. (1994) · Anthropology of Consciousness · doi:10.1525/ac.1994.5.1.16 · Cited by 50 · see citing works
Altered states of consciousness
Blackmore, S., & Troscianko, E. T. (2024) · Routledge eBooks · doi:10.4324/9781003300687-19 · Cited by 46 · see citing works
Ayahuasca in Adolescence: Qualitative Results
de Ríos, M. D., Grob, C. S., López, E., da Silviera, D. X., Alonso, L. K., & Doering-Silveira, E. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399793 · Cited by 34 · see citing works
O uso ritual da ayahuasca
Tromboni, M. (2003) · Mana · doi:10.1590/s0104-93132003000200011 · Cited by 31 · see citing works
Drug Use and Abuse in Cross Cultural Perspective
Rios, M. D., & Smith, D. E. (1977) · Human Organization · doi:10.17730/humo.36.1.p8365jp30956rg77 · Cited by 29 · see citing works
The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies
Osório, F. D. L., de Macedo, L. R. H., Sousa, J. P., Pinto, J. P., Quevedo, J., Crippa, J. A. S., & Hallak, J. E. C. (2011) · Cited by 28 · see citing works
The “Vine of the Soul” vs. The Controlled Substances Act: Implications of the Hoasca Case
Bullis, R. K. (2008) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2008.10400630 · Cited by 24 · see citing works
Psychedelic Sacraments
Baker, J. R. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399799 · Cited by 24 · see citing works
18. United Nations
Connors, J., & Schmidt, M. (2013) · Oxford University Press eBooks · doi:10.1093/he/9780199654574.003.0021 · Cited by 17 · see citing works
The Hallucinogenic Drugs—Curse or Blessing?
Szára, S. (1967) · American Journal of Psychiatry · doi:10.1176/ajp.123.12.1513 · Cited by 15 · see citing works
A Modern-Day Shamanistic Healer in the Peruvian Amazon: Pharmacopoeia and Trance
de Ríos, M. D. (1989) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1989.10472146 · Cited by 9 · see citing works
In the United States District Court for the District of Oregon.
Bonnichsen, R. (1996) · PubMed · Cited by 8 · see citing works
Contrastes e continuidades em uma tradição Amazonica : as regiões da Ayahuasca
Goulart, S. L. (2004) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 6 · see citing works

Flagged first, then by citations

Sorted by citations

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488 · see citing works
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada
Thomas, G., Lucas, P., Capler, N., Tupper, K., & Martin, G. (2013) · Current Drug Abuse Reviews · doi:10.2174/15733998113099990003 · Cited by 330 · see citing works
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306 · see citing works
Neuropharmacology of N,N-dimethyltryptamine
Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268 · see citing works
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Muttoni, S., Ardissino, M., & John, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.076 · Cited by 256 · see citing works
Default Mode Network Modulation by Psychedelics: A Systematic Review
Gattuso, J. J., Perkins, D., Ruffell, S., Lawrence, A. J., Hoyer, D., Jacobson, L. H., Timmermann, C., Castle, D., Rossell, S. L., Downey, L. A., et al. (2023) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac074 · Cited by 256 · see citing works
The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization
Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242 · see citing works
Classic hallucinogens in the treatment of addictions
Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.002 · Cited by 226 · see citing works
Self-citation
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201 · see citing works
Effects of <i>N</i>,<i>N</i>-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00134 · Cited by 171 · see citing works
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. D. M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12779-5 · Cited by 134 · see citing works
The current state of research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging
dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652578 · Cited by 125 · see citing works
Toxicokinetics and Toxicodynamics of Ayahuasca alkaloids N,N-dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: clinical and forensic impact
Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2020) · Pharmaceuticals · doi:10.3390/ph13110334 · Cited by 117 · see citing works
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats
Uthaug, M. V., Mason, N. L., Toennes, S. W., Reckweg, J. T., de Sousa Fernandes Perna, E. B., Kuypers, K. P. C., van Oorsouw, K., Riba, J., & Ramaekers, J. G. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05817-8 · Cited by 112 · see citing works
Psychological and neuropsychological assessment of regular hoasca users
Barbosa, P. C. R., Strassman, R. J., da Silveira, D. X., Areco, K., Hoy, R., Pommy, J., Thoma, R., & Bogenschutz, M. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.09.003 · Cited by 105 · see citing works
Self-citation
Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice.
Oliveira-Lima, A. J., Santos, R., Hollais, A. W., Gerardi-Junior, C. A., Baldaia, M. A., Wuo-Silva, R., Yokoyama, T. S., Costa, J. L., Malpezzi-Marinho, E. L. A., Ribeiro-Barbosa, P. C., et al. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.01.032 · Cited by 91 · see citing works
Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users
Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1567961 · Cited by 76 · see citing works
Assessment of the Psychotherapeutic Effects of Ritual Ayahuasca Use on Drug Dependency: A Pilot Study
Fernández, X., dos Santos, R. G., Cutchet, M., Fondevila, S., González, D., Alcázar, M. Á., Riba, J., Bouso, J. C., & María Fábregas, J. (2014) · The Therapeutic Use of Ayahuasca · doi:10.1007/978-3-642-40426-9_11 · Cited by 36 · see citing works
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects
Aicher, H. D., Mueller, M. J., Dornbierer, D. A., Suay, D., Elsner, C., Wicki, I., Meling, D., Caflisch, L., Hempe, A., Steinhart, C., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1302559 · Cited by 33 · see citing works
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine
Dornbierer, D. A., Marten, L., Mueller, J., Aicher, H. D., Mueller, M. J., Boxler, M., Kometer, M., Kosanic, D., von Rotz, R., Puchkov, M., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1246892 · Cited by 32 · see citing works
Ayahuasca and public health II: Health status in a large sample of ayahuasca-ceremony participants in the Netherlands
Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2077155 · Cited by 24 · see citing works

The Novelty of Ayahuasca Scale and the prediction of intentions to use
Altman, B. R., Mian, M. N., & Earleywine, M. (2020) · Journal of Psychedelic Studies · doi:10.1556/2054.2020.00117 · Cited by 4 · see citing works
Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
Brierley, D. I., & Davidson, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.001 · Cited by 137 · see citing works
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies
SANTOS, R. G. D., Bouso, J. C., & Hallak, J. E. C. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316689030 · Cited by 168 · see citing works
“Ayahuasca turned on my mind’s eye”: Enhanced visual imagery after ayahuasca intake in a man with “blind imagination” (aphantasia)
SANTOS, R. G. D., Enyart, S., Bouso, J. C., Parés, Ò., & Hallak, J. E. C. (2018) · Journal of Psychedelic Studies · doi:10.1556/2054.2018.008 · Cited by 18 · see citing works
Psychometric assessment of the Hallucinogen Rating Scale☆
Riba, J., Rodrı́guez-Fornells, A., Strassman, R. J., & Barbanoj, M. J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00175-7 · Cited by 88 · see citing works
Self-citation

Authors: Barbosa, P. C. R., Mizumoto, S., Bogenschutz, M. P., & Strassman, R. J.
Affiliations: Universidade Estadual de Santa Cruz Ilheus in Bahia State Brazil
Universidade Federal de São Paulo (BR)
University of New Mexico (US)
ORCID: Bogenschutz, Michael P.
Venue: Drug Testing and Analysis
Publisher: Wiley
Published: 2012-07
Volume: 4
Issue: 7-8
Pages: 601-609
ISSN: 1942-7603 (ISSN-L)
1942-7611
DOI: 10.1002/dta.1383
OpenAlex: W1797327965
Cited by: 112
References: 53
Citations by year: 2026: 4 · 2025: 2 · 2024: 7 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 8 · 2018: 13 · 2017: 8 · 2016: 10 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 1
FWCI: 0.65
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 3 d)
Locations: Drug Testing and Analysis (publishedVersion)
PubMed (publishedVersion)
UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords: ayahuasca, N,N-dimethyltryptamine, harmala alkaloids, psychedelic drug use, health effects, mental health, physical health, cognitive effects, emotional impact, drug safety, Amazonian traditional medicine
MeSH terms: Brazil, Cognition, N,N-Dimethyltryptamine, Hallucinogens, Health Status, Humans, Personality, Plant Extracts, Religion, Banisteriopsis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Health status of ayahuasca users

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks